Letter to the Editor: mTOR-Inhibitor-Based Immunosuppression Following Liver Transplantation for Hereditary Hemorrhagic Telangiectasia

Hepatology. 2020 Feb;71(2):762-763. doi: 10.1002/hep.30870. Epub 2020 Jan 26.

Jose Castellote^{1

2

3}, José Maria Mora Luján^{1

4}, Antoni Riera-Mestre^{1

3

4}

¹ HHT Unit, Hospital Universitari Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
² Hepatology and Liver Transplant Unit, Department of Digestive Diseases, Hospital Universitari Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
³ Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.
⁴ Internal Medicine Department, Hospital Universitari Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.

No abstract available

Publication types